Janar Sathananthan, Ole De Backer, and Michael Reardon dive into the newest findings on TAVR from the late-breaking ACURATE IDE trial.

An increased risk of cardiovascular disease may be present as early as 30 years before a type 2 diabetes diagnosis is made, ...

The SMART trial raised questions about balloon-expandable valves in small aortic annuli; these new data offer some answers.

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

Advertisement Advertisement Become a Member Register for TCTMD ® Membership Plans Sign Up for Our Newsletter Receive the the latest news, research, and presentations from major meetings right to your ...

Written to offer advice where formal guidelines fall short, the document urges a balance between bleeding and ischemic risk.

The study was stopped early to allow all patients with advanced PAH the option for treatment with the activin signaling ...

A multistate model that enables real-time risk recalculations may help improve risk stratification for prediction of ...